Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats.

× No keyword cloud information.

7 in total

1. Studies with low dose intravenous diacid ACE inhibitor (perindoprilat) infusions in normotensive male volunteers.

Authors: R J MacFadyen; K R Lees; J L Reid
Journal: Br J Clin Pharmacol Date: 1992-08 Impact factor: 4.335

Review 2. Role of ACE inhibitors in hypertension with left ventricular hypertrophy.

Authors: A M Richards; M G Nicholls; I G Crozier
Journal: Br Heart J Date: 1994-09

3. Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats.

Authors: O Feron; S Salomone; T Godfraind
Journal: Br J Pharmacol Date: 1996-06 Impact factor: 8.739

4. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats.

Authors: W Linz; J Schaper; G Wiemer; U Albus; B A Schölkens
Journal: Br J Pharmacol Date: 1992-12 Impact factor: 8.739

5. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril.

Authors: W Linz; B A Schölkens
Journal: Br J Pharmacol Date: 1992-04 Impact factor: 8.739

6. Ventricular remodeling: insights from pharmacologic interventions with angiotensin-converting enzyme inhibitors.

Authors: S Goldstein; V G Sharov; J M Cook; H N Sabbah
Journal: Mol Cell Biochem Date: 1995 Jun 7-21 Impact factor: 3.396

Review 7. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis.

Authors: W Linz; G Wiemer; J Schaper; R Zimmermann; K Nagasawa; P Gohlke; T Unger; B A Schölkens
Journal: Mol Cell Biochem Date: 1995 Jun 7-21 Impact factor: 3.396

7 in total